COVID-19 is an active, evolving and highly contagious disease caused by a new strain of coronavirus, SARS-CoV2. While around two per cent of people who get the flu in a typical season have severe or life-threatening complications requiring hospitalisation, around 10 per cent of COVID-19 cases result in life-threatening complications.
Here we answer why COVID-19 can be deadlier than the current flu viruses and how our researchers are tackling this disease.
What is coronavirus?
How did COVID-19 get it’s name?
How is COVID-19 spread?
Coronavirus symptoms, diagnosis and treatment
Our COVID-19 research
COVID-19 has highlighted how damaging out-of-control inflammation can be. Patients with severe COVID-19 develop out-of-control inflammation as their bodies try to fight the virus. This triggers a severe hyper-inflammatory response leading to acute respiratory distress syndrome (ARDS) and organ failure. Restricting this inflammatory response could help save lives.
Hudson Institute researchers are using their world-leading inflammation expertise to understand how this response happens and develop treatments to mitigate the deadly inflammation caused by COVID-19.
Tackling acute inflammation in COVID-19 and pathogenic influenza virus
By identifying the molecular mechanisms behind viral lung inflammation and how COVID-19 results in severe lung inflammation, the team will develop and test new and repurposed anti-inflammatory treatments for acute respiratory distress syndrome (ARDS) associated with severe COVID-19 and influenza virus infections.
Single gene disorder in the innate immune pathway in infectious and inflammatory disease
Cancer drug investigated for severe COVID-19 treatment
Using your immune system to fight COVID-19
Making more effective and efficient RNA therapeutics
Hudson Institute specialist guiding Victoria’s RNA future
Lessons from how bats resist COVID could inform new treatments in humans
Dr Emily Camm named STEM Ambassador, Science and Technology Australia
Preparing for the next pandemic
World-leading National Centre for Inflammation Research to be established in Victoria following budget boost
Progressing our COVID-19 research for patients
US President Donald Trump has COVID-19 and is on a cocktail of experimental drugs. What does this mean for his health?
See more news articles about COVID-19
- Monash Health – Dr Ben Rogers
- Rockefeller University – Prof Jean-Laurent Casanova
- Industry Partners Australia
- Australian National University
- Commercial partners in Australia
Explore our labs
Support for people with COVID-19
Hudson Institute scientists cannot provide medical advice.
Find out more about COVID-19.
Keep up-to-date with our latest discoveries